European insurtech rarely moves quietly. The sector has seen hype cycles, tough unit economics, and a few painful resets.

Yet one company keeps pushing forward: Alan.

The French health insurance startup recently reached a €5 billion valuation after raising €100 million in new funding, pushing it above the €4.5 billion valuation it reached in 2024. Not bad for a company founded in 2016.

More interesting than the valuation itself is what sits behind it. The company shows steady growth, expanding markets, and a product experience that behaves more like software than traditional insurance.

A digital insurance model built around product

Alan is not simply selling insurance policies. The company built a digital health insurance platform where users manage reimbursements, access doctors, and track health services inside a single app.

That product focus stands out compared with legacy insurers, where fragmented infrastructure and paperwork-heavy processes still dominate. Alan designed its offering around a clean software experience.

Companies purchase coverage for employees, and users interact with the service digitally through the platform. The result feels closer to a SaaS product wrapped around insurance infrastructure than a traditional insurer.

That approach appears to resonate. Alan now serves around 1 million employees, freelancers, and retirees across its platform.

Growth numbers investors can understand

Behind the valuation sits a fairly clear growth story.

Alan reported €785 million in annual recurring revenue in 2025, showing strong year-on-year expansion. The company is also moving closer to operating break-even while continuing to invest in expansion and product development.

This balance matters. Insurtech companies often struggle with the tension between growth and profitability. Alan still reports losses, but those losses have been shrinking relative to revenue.

Meanwhile, the company continues expanding geographically. After building its base in France, Alan moved into Belgium, Spain, and Canada, adding large corporate clients along the way.

A different type of insurtech ambition

What makes Alan interesting is not only the valuation or the growth numbers. The longer-term ambition stands out.

The company continues investing heavily in technology and product development. Part of the new funding will support further work on technology and artificial intelligence capabilities.

That direction points toward a broader goal: building a health platform, not simply a digital insurance layer.

Scaling such a platform across countries will not be simple. Healthcare systems vary widely and regulation is complex. Still, Alan has already crossed a difficult milestone.

The company became the first new independent health insurer licensed in France since the 1980s, showing how much regulatory groundwork the company has already completed.

Key takeaways for fintech startups

Several practical lessons stand out from Alan’s trajectory.

• Product quality still matters, even in highly regulated sectors. A strong user experience can become a real competitive advantage.

• Clear revenue growth helps maintain investor confidence and supports continued funding rounds.

• Regulation is difficult but defensible. Securing licenses can create long-term barriers for competitors.

• International expansion usually follows strong domestic traction rather than the other way around.

If you are building a fintech startup and thinking about positioning, growth strategy, or product direction, reach out to us. We help fintech founders sharpen their story and scale their business.